Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The OVOL1 gene, controlled by β-catenin, is crucial for creating hair follicles.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Immune changes and specific genes contribute to male hair loss.

Specific miRNA profiles can help diagnose and treat alopecia areata.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Cholesterol issues in skin and hair may cause permanent hair loss by triggering inflammation.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Personalized treatments for hair loss are becoming more effective by using genetic information.